Wild; Carl T.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wild; Carl T..The latest application filed is for "triterpene amine derivatives".

Company Profile

0.15.23

Wild; Carl T. - Gaithersburg MD
Wild; Carl T. - Durham NC

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Triterpene amine derivatives Grant 11,236,122 - Nitz , et al. February 1, 2	2022-02-01
Triterpene Amine Derivatives App 20210253627 - NITZ; Theodore J. ; et al.	2021-08-19
Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein Grant 8,318,425 - Salzwedel , et al. November 27, 2	2012-11-27
Methods of Eliciting Broadly Neutralizing Antibodies Targeting HIV-1 GP41 App 20110142847 - Wild; Carl T. ; et al.	2011-06-16
Methods And Compositions For Inhibition Of Membrane Fusion-associated Events, Including Hiv Transmission App 20100291680 - Bolognesi; Dani Paul ; et al.	2010-11-18
Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein App 20100221264 - Salzwedel; Karl ; et al.	2010-09-02
Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein Grant 7,537,765 - Salzwedel , et al. May 26, 2	2009-05-26
Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein App 20080233559 - SALZWEDEL; Karl ; et al.	2008-09-25
Inhibition of Hiv-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein App 20080200550 - Salzwedel; Karl ; et al.	2008-08-21
Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof Grant 7,365,221 - Allaway , et al. April 29, 2	2008-04-29
Antiretroviral combination therapy App 20080039428 - Allaway; Graham ; et al.	2008-02-14
Methods of eliciting broadly neutralizing antibodies targeting HIV-1 gp41 Grant 7,311,916 - Wild , et al. December 25, 2	2007-12-25
Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids Grant 7,273,614 - Bolognesi , et al. September 25, 2	2007-09-25
Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids App 20070202127 - Bolognesi; Dani Paul ; et al.	2007-08-30
Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission App 20070037141 - Bolognesi; Darii Paul ; et al.	2007-02-15
Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids Grant 7,122,190 - Bolognesi , et al. October 17, 2	2006-10-17
Novel betulin derivatives, preparation thereof and use thereof App 20060205697 - Robinson; Gary N. ; et al.	2006-09-14
Novel triterpene derivatives, preparation thereof and use thereof App 20050148561 - Wild, Carl T. ; et al.	2005-07-07
Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof App 20050020548 - Allaway, Graham P. ; et al.	2005-01-27
Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein App 20050015039 - Salzwedel, Karl ; et al.	2005-01-20
Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein App 20040265320 - Salzwedel, Karl ; et al.	2004-12-30
Methods for inhibition of membrane fusion-associated events, including HIV transmission Grant 6,824,783 - Bolognesi , et al. November 30, 2	2004-11-30
Methods of eliciting broadly neutralizing antibodies targeting HIV-1 gp41 App 20040213801 - Wild, Carl T. ; et al.	2004-10-28
Substituted 3',4'-di-O-camphanoyl-(+)-cis-khellactone analogs, compositions thereof, and methods for using thereof Grant 6,768,007 - Lee , et al. July 27, 2	2004-07-27
Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof App 20040131629 - Allaway, Graham P. ; et al.	2004-07-08
Method for detecting viral inactivating agents App 20040132011 - Allaway, Graham P. ; et al.	2004-07-08
Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids App 20040052820 - Bolognesi, Dani Paul ; et al.	2004-03-18
Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids App 20040033235 - Bolognesi, Dani Paul ; et al.	2004-02-19
Compounds which inhibit HIV replication App 20030181382 - Wild, Carl T. ; et al.	2003-09-25
Assay for detection of viral fusion inhibitors Grant 6,605,427 - Wild , et al. August 12, 2	2003-08-12
Substituted 3',4' -Di-O-camphanoyl-(+)-cis-khellactone analogs, compositions thereof, and methods for using thereof App 20030008891 - Lee, Kuo-Hsiung ; et al.	2003-01-09
Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission Grant 6,479,055 - Bolognesi , et al. November 12, 2	2002-11-12
Methods for the inhibition of respiratory syncytial virus transmission Grant 6,440,656 - Bolognesi , et al. August 27, 2	2002-08-27
Assay for detection of viral fusion inhibitors App 20020094521 - Wild, Carl T. ; et al.	2002-07-18
Method for generating immunogens that elicit neutralizing antibodies against fusion-active regions of HIV envelope proteins App 20020010317 - Wild, Carl T. ; et al.	2002-01-24
Synthetic peptide inhibitors of HIV transmission Grant 6,133,418 - Bolognesi , et al. October 17, 2	2000-10-17
Compounds which inhibit HIV replication Grant 5,656,480 - Wild , et al. August 12, 1	1997-08-12
Synthetic peptide inhibitors of HIV transmission Grant 5,464,933 - Bolognesi , et al. November 7, 1	1995-11-07

Company Registrations

NCAGE Code	47K94	WILD CARL T
CAGE Code	47K94	WILD, CARL T

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.